TY  - JOUR

T1  - Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy

JO  - Cancer Medicine

UR  - https://eprints.whiterose.ac.uk/id/eprint/101899

UR  - http://dx.doi.org/10.1002/cam4.643

PY  - 2016/05/12

AU  - Latimer NR

AU  - Bell H

AU  - Abrams KR

AU  - Amonkar MM

AU  - Casey M

ED  - 

DO  - DOI: 10.1002/cam4.643

PB  - Wiley Open Access

Y2  - 2025/10/31

ER  -